ArticlePharmacological reports : PR2022

The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach.

Faezeh Hosseinzadeh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.